Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-02-08
Original SEC Filing: Click here

---

Webplus: SVA/20170208/6-K/2_EX-99.1/000.htm SEC Original: v458738_ex99-1.htm
Sinovac Reports Unaudited Third Quarter 2016 Financial Results BEIJING, Nov. 28, 2016 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter ended September 30, 2016. Mr. Weidong Yin, Chairman, President and CEO of the Sinovac, commented, “Our third quarter revenue rebounded from a slower first half of the

---

---

Webplus: SVA/20170208/6-K/1/000.htm SEC Original: v458738_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-02-08CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085